CD8A and neoplasm: Human patients with cancer responding to PD1 blockade have tumor-reactive T cells in circulation, as demonstrated by TCR clonotype tracking studies that have matched activated CD8 T cells from peripheral blood to clonotypes found in the tumor (58–60).